Sun Pharma, DRL recall drugs in US

NEW DELHI: Sun Pharma and Dr Reddy’s Laboratories are recalling products in the American market due to manufacturing issues, the US Food and Drug Administration (US FDA) has said.

In its latest Enforcement Report, the US health regulator stated that a US-based unit of Sun Pharma is recalling 35,069 bottles of medication used to treat high pressure inside the eye due to glaucoma or other eye diseases. New Jersey-based Sun Pharmaceutical Industries is recalling the affected lot of Xelpros (latanoprost ophthalmic emulsion) due to “out of specification for particulate matter test”. The company initiated the voluntary Class III recall in the US on April 22 this year, the US FDA stated.

In a separate filing, the US FDA said that a US-based arm of Dr Reddy’s Laboratories is recalling 1,176 bottles of an immunosuppressant medication. Dr Reddy’s Laboratories is recalling the affected lot of Sirolimus Tablets due to “failed impurities/degradation specifications”, it said. The company initiated the Class III recall on May 1, 2024.

Ready to Master Stock Valuation? ET’s Workshop is just around the corner!